We are international
• treatment options TEXT SIZE   
drugs & procedures in clinical trials    back

ASH 2011: Dr. Palumbo - Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study
Antonio Palumbo, MD
University of Torino
AOU S. Giovanni Battista
Torino, Italy

To view the video full screen, click on the small button next to the volume control in the lower right hand corner.

 related articles